1. Search Result
Search Result
Results for "

L141F

" in MedChemExpress (MCE) Product Catalog:

1

Inhibitors & Agonists

1

Screening Libraries

Cat. No. Product Name
  • HY-L141
    2550 compounds

    Drug repurposing (also called drug repositioning, reprofiling, or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, for example, lower risk of failure, less investment, and shorter development timelines. But drug repositioning projects are also subject to several risks, including regulatory and intellectual property issues. So the off-patent drugs are optimal for repositioning because of their immediate availability for clinical studies, with high feasibility and relatively low risk.

    MCE carefully prepared a unique collection of 2550 off-patent drugs, which is a good choice for drug repurposing.

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: